Format

Send to

Choose Destination
Curr Opin Pharmacol. 2002 Dec;2(6):708-16.

Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.

Author information

1
Department of Endocrinology, Lapeyronie Hospital, 34295, Cedex 5, Montpellier, France. e.renard@chu-montpellier.fr

Abstract

Although subcutaneous insulin infusion from portable pumps is the current optimal therapy for type 1 diabetic patients, implantable pumps using the intraperitoneal route allow increased blood glucose stability and lowered incidence of severe hypoglycemia. Subcutaneously implanted enzymatic glucose sensors provide continuous interstitial glucose monitoring, but this may differ from the real-time blood glucose levels. Preliminary investigations of intravascular enzymatic sensors demonstrate their clinical acceptability and accuracy and the possibility of developing closed-loop insulin delivery by combination with implantable pumps.

PMID:
12482735
DOI:
10.1016/s1471-4892(02)00216-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center